- Home
- OGEN vs FTFT Comparison
OGEN vs FTFT Comparison
Compare OGEN & FTFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OGEN
- FTFT
- Stock Information
- Founded
- OGEN 1996
- FTFT N/A
- Country
- OGEN United States
- FTFT United States
- Employees
- OGEN N/A
- FTFT N/A
- Industry
- OGEN Biotechnology: Pharmaceutical Preparations
- FTFT Business Services
- Sector
- OGEN Health Care
- FTFT Consumer Discretionary
- Exchange
- OGEN Nasdaq
- FTFT Nasdaq
- Market Cap
- OGEN 2.5M
- FTFT 5.4M
- IPO Year
- OGEN N/A
- FTFT N/A
- Fundamental
- Price
- OGEN $1.50
- FTFT $1.28
- Analyst Decision
- OGEN
- FTFT
- Analyst Count
- OGEN 0
- FTFT 0
- Target Price
- OGEN N/A
- FTFT N/A
- AVG Volume (30 Days)
- OGEN 1.1M
- FTFT 44.3K
- Earning Date
- OGEN 08-08-2025
- FTFT 08-18-2025
- Dividend Yield
- OGEN N/A
- FTFT N/A
- EPS Growth
- OGEN N/A
- FTFT N/A
- EPS
- OGEN N/A
- FTFT N/A
- Revenue
- OGEN N/A
- FTFT $2,031,913.00
- Revenue This Year
- OGEN N/A
- FTFT N/A
- Revenue Next Year
- OGEN N/A
- FTFT N/A
- P/E Ratio
- OGEN N/A
- FTFT N/A
- Revenue Growth
- OGEN N/A
- FTFT N/A
- 52 Week Low
- OGEN $1.35
- FTFT $1.01
- 52 Week High
- OGEN $75.60
- FTFT $5.70
- Technical
- Relative Strength Index (RSI)
- OGEN 27.35
- FTFT 54.76
- Support Level
- OGEN $1.35
- FTFT $1.01
- Resistance Level
- OGEN $4.19
- FTFT $1.16
- Average True Range (ATR)
- OGEN 0.43
- FTFT 0.10
- MACD
- OGEN -0.22
- FTFT 0.03
- Stochastic Oscillator
- OGEN 5.14
- FTFT 100.00
About OGEN Oragenics Inc.
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.
About FTFT Future FinTech Group Inc.
Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and a cryptocurrency mining farm in the U.S. The company's reportable segments include asset management services, supply chain financing and trading, and others.